We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
Premature babies at Brisbane’s Mater Mothers’ Hospital are being fed expressed milk just hours after being born as part of a program to improve health outcomes of pre ...
Sandeep Mann can’t wipe the smile off her face as she nurses her newborn baby girl – a special delivery on Valentine’s Day.
Love can bloom in the most unexpected places, including an open-place office.
Over-confident DIYers are ending up in hospital as a result of home maintenance repairs going wrong over the holiday period, according to Mater plastic and ...
Mater nurses on the frontline of the COVID-19 pandemic at Brisbane’s Mater hospital will be nourished with hearty home-cooked meals, thanks to a Brisbane café owner.
Mater Foundation is driving a call to arms for the community to show their support for frontline health workers who are working tirelessly during the nation’s Omicron ...
Louise loved flying high as a QANTAS flight attendant but the call to be part of the solution to the current COVID-19 pandemic was too strong for her to ignore.
Stay up-to-date using Mater’s combined Policy and Procedure Library
The Mater Research Publication Recognition Scheme winners have been announced.
Mater has launched a new digital tool to provide virtual care to COVID-19 patients in their own homes, alleviating pressure on stretched hospital and healthcare services.
As COVID-19 continues to challenge health workers, it’s important to remember to care for yourself as well. Find some self-care tips in this video.
Mater Research will begin trialling a new targeted immunotherapy in 2022 to treat a rare but devastating blood cancer thanks to a $2.8 million Medical Research Future ...